LAI, PIERO LUIGI
 Distribuzione geografica
Continente #
EU - Europa 9.542
AS - Asia 392
SA - Sud America 78
NA - Nord America 36
AF - Africa 9
Totale 10.057
Nazione #
IT - Italia 9.530
SG - Singapore 156
CN - Cina 118
VN - Vietnam 86
BR - Brasile 49
US - Stati Uniti d'America 30
AR - Argentina 19
HK - Hong Kong 10
ID - Indonesia 6
MX - Messico 5
ZA - Sudafrica 5
BD - Bangladesh 4
EC - Ecuador 3
IN - India 3
RU - Federazione Russa 3
AZ - Azerbaigian 2
CO - Colombia 2
FR - Francia 2
GB - Regno Unito 2
IQ - Iraq 2
MA - Marocco 2
UA - Ucraina 2
UY - Uruguay 2
AL - Albania 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
IL - Israele 1
NL - Olanda 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 10.057
Città #
Genova 5.104
Genoa 2.675
Rapallo 952
Vado Ligure 768
Singapore 77
Ho Chi Minh City 42
Beijing 29
Bordighera 27
Ashburn 18
Hanoi 16
Hong Kong 9
Tianjin 9
São Paulo 6
Da Nang 4
Vinh 3
Baku 2
Brasília 2
Foshan 2
Guangzhou 2
Guayaquil 2
Johannesburg 2
Lấp Vò 2
Medford 2
Mexico City 2
Nam Định 2
Quảng Ngãi 2
San Jose 2
Thái Nguyên 2
Viamão 2
Ambato 1
Araçatuba 1
Asunción 1
Atibaia 1
Barranquilla 1
Basra 1
Batam 1
Belford Roxo 1
Belgrade 1
Belo Horizonte 1
Biên Hòa 1
Boardman 1
Bofete 1
Bogotá 1
Bragado 1
Brakpan 1
Brooklyn 1
Bukhara 1
Bắc Ninh 1
Campinas 1
Can Tho 1
Canaã dos Carajás 1
Cape Town 1
Capivari 1
Carapicuíba 1
Casablanca 1
Caseros 1
Castanhal 1
Catanduva 1
Caçador 1
Chacabuco 1
Chengdu 1
Chennai 1
Clorinda 1
Conselheiro Lafaiete 1
Constantine 1
Crespo 1
Cuiabá 1
Culiacán 1
Dallas 1
Dhaka 1
Dokki 1
Donetsk 1
Duque de Caxias 1
Elbasan 1
Encantado 1
Goiânia 1
Gresik 1
Guadalajara 1
Ha Long 1
Hangzhou 1
Hưng Yên 1
Hải Dương 1
Ipatinga 1
Iramaia 1
Itabuna 1
Ivanovo 1
Jakarta 1
Jaraguá 1
Joinville 1
Kostomuksha 1
Kowloon City 1
Kyiv 1
Laferrere 1
Lahore 1
Lima 1
Londrina 1
Los Angeles 1
Maceió 1
Maldonado 1
Mar del Plata 1
Totale 9.838
Nome #
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? 203
Age-related differences in the accuracy of web query-based predictions of influenza-like illness 198
An overview on the implementation of HPV vaccination in Europe 180
Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines 180
Do the omeprazole family compounds exert a protective effect against influenza-like illness? 175
Cost-benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria 170
A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformation 170
Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly 164
Safety and tolerability of bivalent HPV vaccine: an Italian post-licensure study 161
Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic. 156
Cause of death among people with AIDS in Liguria (Italy). A different pattern for intravenous drug users? 155
An overview of current and potential use of information and communication technologies for immunization promotion among adolescents 155
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 152
Influenza vaccination: from epidemiological aspects and advances in research to dissent and vaccination policies 151
Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy 149
Neisseria meningitidis B vaccines 143
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 143
Chlamydia trachomatis prevalence and chlamydial/ HPV co-infection among HPV-unvaccinated young Italian females with normal cytology 143
Long-term decline of (137)Cs concentration in honey in the second decade after the Chernobyl accident 142
Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? 142
Influenza vaccination in italian healthcare workers (2018–2019 season): Strengths and weaknesses. results of a cohort study in two large italian hospitals 135
Benefit-cost evaluation of Influenza vaccination in the elderly in the Italian Region of Liguria 134
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus 133
People living with undiagnosed HIV infection and a low CD4 count: Estimates from surveillance data, Italy, 2012 to 2014 129
Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V® and Fluad®) in preventing hospitalization for influenza and pneumonia in the elderly. A matched case-control study 128
Aflunov: a prepandemic influenza vaccine 128
Burden of rotavirus associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance 125
Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study 124
Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra® 124
La vaccinazione universale dei bambini contro l’influenza con il vaccino Vaxigrip Tetra® in Italia: risultati di una valutazione di Health Technology Assessment (HTA) [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment] 123
Neisseria meningitidis B vaccines: recent advances and possible immunization policies. 122
Influenza epidemiology in Italy two years after the 2009-2010 pandemic: Need to improve vaccination coverage 121
Influenza Burden on Italian Paediatric Population: Five year Nation-wide Surveillance and Correlation between Epidemiological and Virological Data 119
Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO®) 119
Virological investigation on aerosol from waste depuration plants 117
Anamnestic response to administration of purified non-adsorbent hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres. 117
Utility of virosomal adjuvated influenza vaccines - a review of the literature. 114
Valutazione della tollerabilità del vaccino anti-HPV nelle donne liguri 114
A pharmacoeconomic appraisal of the strategy to tackle the H1N1v (A/California/07/09) pandemic in Italy: relevance of the CIRI-IV surveillance system. 114
Why the anti-meningococcal b vaccination during adolescence should be implemented in italy: An overview of available evidence 114
Influenza epidemiology in Italy two years after the 2009-2010 pandemic: Need to improve vaccination coverage. 113
Benefit-cost evaluation of Influenza vaccination in elderly people in Liguria, Italy 109
In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains 109
Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta-regression analysis 108
Assessment and prevention of radioactive risk due to 222Radon in commercial concerns of Genoa 104
Relevance of air condititioning for 222Radon concentration in commercial concerns of the Savona Province, Italy 103
VIROLOGICAL SURVEILLANCE AS A TOOL FOR ASSESSING HUMAN PAPILLOMAVIRUS VACCINATION 103
How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines 103
Development of a sensitive real-time PCR for simultaneous detection and subtyping of influenza A and B viruses 102
Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review 102
PREVALENZA DEI TIPI DI HPV NELLE DONNE ITALIANE (16-26 ANNI) SOTTOPOSTE A SCREENING VOLONTARIO DEL CANCRO CERVICALE. VALUTAZIONE DELL’INCIDENZA CUMULATIVA E DELLA POSSIBILE ESTENSIONE DELLA VACCINAZIONE CON IL VACCINO BIVALENTE. 101
NEW VERSUS OLD MENINGOCOCCAL GROUP B VACCINES: HOW THE NEW ONES MAY BENEFIT INFANTS & TODDLERS 101
Prevalence of the Human Papillomavirus genotypes in Italian women undergoing voluntary cervical cancer screening: Evaluation of cumulative incidence from 16 to 26 years of age and evaluationof the effect of extending Italian vaccination policy with bivalent vaccine. 96
Diminuzione delle coperture vaccinali per influenza: riflessi sull'epidemiologia stagionale 2012-13 in Liguria. 94
Burden dell’influenza nella popolazione italiana nel periodo compreso tra il 1999 e il 2004: correlazioni tra sorveglianza clinico-epidemiologica e caratterizzazione antigenica e molecolare dei virus influenzali 93
Relevance of main factor affecting Radon concentration in multi-storey buildings in Liguria (Northern Italy) 93
Neisseria meningitidis: pathogenetic mechanisms to overcome the human immune defences 93
Tubercolosis today: populations at risk 93
Weekly monitoring of Influenza Like Illness (ILI) and other acute respiratory infections (ARI) impact on pediatric population during the last two years in 10 Italian Regions. 92
Health Technology Assessment (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy 90
Live attenuated influenza vaccine-a review 89
Influenza surveillance by general practitioners and paediatricians in the Italian region of Liguria in 1999-2002 89
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: influenza life-cycle and currently available drugs 88
Burden of typhoid fever and cholera: Similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas 86
Valutazione costi-benefici della vaccinazione influenzale in Liguria 85
Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season 83
Vaccination promotion within a framework of public health education 83
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy 83
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 78
Valutazione della copertura antinfluenzale in Liguria mediante somministrazione di questionario telefonico 77
Valutazione costi/benefici della vaccinazione influenzale negli anziani in Liguria (Italia) 76
Efficacia dei vaccini adiuvati e ricadute farmaco-economiche 76
Tobacco smoking among students in an urban area in Northern Italy 76
Hepatitis B immunization and anti-HBs quantitation: comparative performance of thirteen commercial immunoassays 75
Le vaccinazioni dell'adulto a rischio e dell'anziano 74
EPIDEMIOLOGIA DELL’INFLUENZA IN ITALIA DOPO LA PANDEMIA 2009-10. NECESSITÀ DI MIGLIORARE LE COPERTURE VACCINALI. 74
Influenza vaccination of elderly: relaunch time 73
Health Technology Assessment e vaccinazioni in Italia 72
Implementazione dei tassi di copertura vaccinale antinfluenzale nel personale sanitario dell'A.U.O. San Martino di Genova durante la stagione 2005-06 72
Prevalenza dell’anti-HCV in pazienti plurioperati 71
Today's influenza vaccines. Why an adjuvant is needed and How it works 69
Valutazione dell'impatto epidemiologico, sanitario ed aconomico della malattia da herpes zoster in Italia 67
HTA in vaccine prevention: application to vaccinations against invasive diseases. 67
Vaccinations for adults at risk and the elderly 66
The urban myth of the association between neurological disorders and vaccinations. 63
Influenza vaccination coverage in Italy in 1999-2013: impact on incidence of ILIs in the elderly. 60
No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020 60
Influenza surveillance in the Italian region of Liguria in the winter of 1999-2000 by general practitioners and paediatricians: socio-economic implications 59
Co-detection of respiratory pathogens among ILI patients: characterization of samples collected during the 2018/19 and 2019/20 pre-pandemic seasons 58
Meningococcal B vaccination strategies and their practical application in Italy 58
UTILIZZO DELL'HTA IN PREVENZIONE VACCINALE: APPLICAZIONE ALLE VACCINAZIONI CONTRO LE MALATTIE INVASIVE 54
Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine 47
Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59®-adjuvanted influenza vaccine in older adults: Results from three consecutive seasons 46
Demographic and Socio-economic Determinants of Poor HIV-risk Perception at First HIV Diagnosis: Analysis of the HIV Surveillance Data, Italy 2010-2016 44
Exploring case definitions and the natural history of respiratory syncytial virus in adult outpatients: First-season results of the RESPIRA-50 study 43
Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine 36
The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment 21
Totale 10.186
Categoria #
all - tutte 34.938
article - articoli 29.312
book - libri 0
conference - conferenze 5.254
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 372
Totale 69.876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021250 0 0 0 0 0 40 22 26 39 41 43 39
2021/2022995 21 98 74 96 48 45 55 252 63 77 41 125
2022/20231.138 110 81 16 106 175 211 4 76 176 6 164 13
2023/2024542 18 86 13 75 34 92 36 55 40 7 34 52
2024/20251.853 54 133 60 130 260 198 170 249 49 94 196 260
2025/20261.443 406 66 258 280 378 55 0 0 0 0 0 0
Totale 10.186